1.
Kabir AL, Islam KMK, Rahman M, Shah MS, Ahmed M, Sharmin M, Roy CK, Rahman F. Early Molecular Response to Imatinib Mesylate Predicts Long-Term Outcomes in CML Patients in A Postgraduate Research Institute — A single center Study. Planet (Barisal) [Internet]. 2024 Feb. 10 [cited 2024 Jul. 3];7(01):255-66. Available from: https://bdjournals.org/index.php/planet/article/view/427